Liyu He

4.0k total citations · 2 hit papers
93 papers, 3.1k citations indexed

About

Liyu He is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Liyu He has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Nephrology, 25 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Liyu He's work include Renal Diseases and Glomerulopathies (35 papers), Chronic Kidney Disease and Diabetes (19 papers) and Dialysis and Renal Disease Management (13 papers). Liyu He is often cited by papers focused on Renal Diseases and Glomerulopathies (35 papers), Chronic Kidney Disease and Diabetes (19 papers) and Dialysis and Renal Disease Management (13 papers). Liyu He collaborates with scholars based in China, United States and Japan. Liyu He's co-authors include Zheng Dong, Chengyuan Tang, Fuyou Liu, Youming Peng, Hong Liu, Lin Sun, Xiaofei Peng, Yu Liu, Guoyong Liu and Zhiwen Liu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Kidney International.

In The Last Decade

Liyu He

87 papers receiving 3.0k citations

Hit Papers

The mitochondria-targeted antioxidant MitoQ ameliorated t... 2016 2026 2019 2022 2016 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1
    2016 456 citations Chengyuan Tang, Liyu He et al. profile →
  2. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
    2017 322 citations Liyu He, Qingqing Wei et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyu He China 27 1.3k 1.2k 614 372 370 93 3.1k
Shikun Yang China 27 1.2k 0.9× 817 0.7× 444 0.7× 317 0.9× 217 0.6× 78 2.8k
Songming Huang China 36 1.9k 1.5× 1.2k 1.0× 416 0.7× 545 1.5× 419 1.1× 183 4.3k
Niansong Wang China 38 1.9k 1.4× 1.6k 1.3× 514 0.8× 389 1.0× 471 1.3× 193 4.6k
Zhanjun Jia China 35 2.0k 1.6× 1.0k 0.8× 426 0.7× 541 1.5× 432 1.2× 174 4.3k
Sandra Rayego‐Mateos Spain 31 1.3k 1.0× 951 0.8× 262 0.4× 256 0.7× 524 1.4× 72 3.1k
Hong Liu China 31 1.2k 0.9× 1.5k 1.2× 310 0.5× 483 1.3× 581 1.6× 156 3.4k
Jinghong Zhao China 35 1.3k 1.0× 1.3k 1.1× 305 0.5× 235 0.6× 391 1.1× 156 3.5k
Dan‐Qian Chen China 34 2.3k 1.8× 1.2k 1.0× 444 0.7× 252 0.7× 296 0.8× 64 4.5k
Yanggang Yuan China 26 1.1k 0.8× 771 0.7× 345 0.6× 267 0.7× 124 0.3× 86 2.3k
Adrián M. Ramos Spain 30 1.3k 1.0× 870 0.7× 211 0.3× 277 0.7× 430 1.2× 62 3.0k

Countries citing papers authored by Liyu He

Since Specialization
Citations

This map shows the geographic impact of Liyu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyu He more than expected).

Fields of papers citing papers by Liyu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyu He. The network helps show where Liyu He may publish in the future.

Co-authorship network of co-authors of Liyu He

This figure shows the co-authorship network connecting the top 25 collaborators of Liyu He. A scholar is included among the top collaborators of Liyu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyu He. Liyu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Li, Hao, et al.. (2024). IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 167022–167022. 9 indexed citations
5.
Li, Guoyan, et al.. (2024). Compound Fault Diagnosis of Planetary Gearbox Based on Improved LTSS-BoW Model and Capsule Network. Sensors. 24(3). 940–940. 4 indexed citations
6.
He, Liyu, Tingting Han, Jialiang Ren, et al.. (2024). HRCT findings predict 1-year mortality in patients with acute exacerbation of idiopathic inflammatory myopathies-associated interstitial lung disease. Heliyon. 10(11). e31510–e31510. 1 indexed citations
7.
Cai, Juan, Chenrui Li, Ming Yang, et al.. (2023). 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling. Molecular Medicine. 29(1). 58–58. 43 indexed citations
8.
Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Myokines: Novel therapeutic targets for diabetic nephropathy. Frontiers in Endocrinology. 13. 1014581–1014581. 11 indexed citations
9.
Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Lipid droplet - mitochondria coupling: A novel lipid metabolism regulatory hub in diabetic nephropathy. Frontiers in Endocrinology. 13. 1017387–1017387. 25 indexed citations
10.
Yang, Ming, Shilu Luo, Jinfei Yang, et al.. (2022). Crosstalk between the liver and kidney in diabetic nephropathy. European Journal of Pharmacology. 931. 175219–175219. 6 indexed citations
11.
Yang, Ming, Wei Chen, Liyu He, et al.. (2022). A Glimpse of necroptosis and diseases. Biomedicine & Pharmacotherapy. 156. 113925–113925. 19 indexed citations
12.
Chen, Yinyin, Yiya Yang, Zhiwen Liu, & Liyu He. (2021). Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function. Metabolism. 128. 154959–154959. 36 indexed citations
13.
Tang, Xiaofang, et al.. (2019). 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria. Kidney & Blood Pressure Research. 44(2). 245–263. 19 indexed citations
14.
15.
Peng, Xiaofei, Tao Yang, Guoyong Liu, et al.. (2018). Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. International Immunopharmacology. 65. 448–457. 61 indexed citations
16.
He, Liyu, Qingqing Wei, Jing Liu, et al.. (2017). AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney International. 92(5). 1071–1083. 322 indexed citations breakdown →
17.
Liu, Guoyong, Qiang Wang, Yan Shi, et al.. (2017). Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway. Pharmacology. 100(5-6). 253–260. 10 indexed citations
18.
He, Liyu, Xian Chen, Xiaofei Peng, et al.. (2016). Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy. International Urology and Nephrology. 48(11). 1855–1861. 4 indexed citations
19.
He, Liyu, Xiaofei Peng, Chengyuan Tang, et al.. (2015). Synthetic Double-Stranded RNA Poly(I:C) Aggravates IgA Nephropathy by Triggering IgA Class Switching Recombination through the TLR3-BAFF Axis. American Journal of Nephrology. 42(3). 185–197. 16 indexed citations
20.
He, Liyu, Xiaofei Peng, Jiefu Zhu, et al.. (2014). Mangiferin Attenuate Sepsis-Induced Acute Kidney Injury via Antioxidant and Anti-Inflammatory Effects. American Journal of Nephrology. 40(5). 441–450. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shikun Yang Breakdown of academic impact, for papers by Songming Huang Breakdown of academic impact, for papers by Niansong Wang Breakdown of academic impact, for papers by Zhanjun Jia Breakdown of academic impact, for papers by Sandra Rayego‐Mateos Breakdown of academic impact, for papers by Hong Liu Breakdown of academic impact, for papers by Jinghong Zhao Breakdown of academic impact, for papers by Dan‐Qian Chen Breakdown of academic impact, for papers by Yanggang Yuan Breakdown of academic impact, for papers by Adrián M. Ramos
Rankless by CCL
2026